Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What CAGR is Anticipated for the Preclinical Assets Market During the Forecast Period, and Why?

The preclinical assets market has expanded strongly in recent years. It is forecasted to increase from $5.87 billion in 2024 to $6.4 billion in 2025, at a CAGR of 9.1%. The historical expansion of this market has been supported by the growing need for drug development, progress in biotechnology, evolving regulatory requirements, rising research funding, and collaborative research initiatives.

The Preclinical Assets market is expected to witness strong growth, reaching $9.3 billion in 2029 at a CAGR of 9.8%. Growth drivers include the rise of precision medicine and personalized therapies, AI and machine learning applications, biobanking expansion, a growing focus on rare diseases, and government funding and initiatives. Notable trends in this market include advancements in imaging techniques, the use of 3D organoid models, multi-omics integration, enhanced predictive models, and automation with high-throughput screening.

What Key Drivers Are Accelerating the Growth of the preclinical assets Market During the Forecast Period?

The growing rate of drug discovery is expected to accelerate the growth of the preclinical assets market. Drug discovery identifies new chemical substances that can become medicines, and preclinical assets provide essential data to select candidates for clinical trials. For example, in June 2023, the European Federation of Pharmaceutical Industries and Associations noted a significant rise in the European pharmaceutical industry’s production, growing from $352.48 billion in 2021 to $369.95 billion in 2022. Hence, the rise in drug discovery is supporting the preclinical assets market.

Request Your Free Preclinical Assets Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12600&type=smp

Which Companies Are Poised to Shape the Future of the Preclinical Assets Market?

Major companies operating in the preclinical assets market include:

• Laboratory Corporation of America_x000D_

• IQVIA Inc._x000D_

• ICON PLC_x000D_

• Eurofins Scientific SE_x000D_

• PPD Inc._x000D_

What Are the Latest Innovations and Trends Influencing the Preclinical Assets Market?

Product innovation is key in the preclinical assets market, where companies are introducing new solutions to strengthen their market position. For example, in April 2022, Charles River Laboratories International, a US-based pharmaceutical company, and Valo Health Inc., a US-based technology company, launched Logica, an AI-powered drug solution. Logica translates biological insights into optimized preclinical assets by integrating Charles River’s preclinical expertise with Valo’s AI-powered platform, revolutionizing drug discovery and providing clients with highly qualified leads.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/preclinical-assets-global-market-report

What Are the Major Categories and Their Growth Dynamics in the Preclinical Assets Market?

The preclinical assets market covered in this report is segmented –

1) By Service: Bioanalysis And DMPK (Drug Metabolism And Pharmacokinetic) Studies, Toxicology Testing, Compound Management, Safety Pharmacology, Other Services

2) By Model Type: Patient Derived Organoid (PDO) Model, Patient Derived Xenograft Model

3) By End User: Biopharmaceutical Companies, Government Institutes, Other End-Users

Subsegments:

1) By Bioanalysis And DMPK (Drug Metabolism And Pharmacokinetic) Studies: Pharmacokinetics (PK) Studies, Pharmacodynamics (PD) Studies, Bioanalytical Method Development

2) By Toxicology Testing: Acute Toxicity Testing, Chronic Toxicity Testing, Genotoxicity Testing, Carcinogenicity Testing

3) By Compound Management: Compound Library Management, Sample Storage And Retrieval, High-Throughput Screening Support

4) By Safety Pharmacology: Cardiovascular Safety Assessments, Neurotoxicity Evaluations, Respiratory Safety Evaluations

5) By Other Services: Regulatory Support, Preclinical Study Design And Consulting, Custom Assay Development

What Regions Are Contributing Significantly to the Growth of the Preclinical Assets Market?

North America was the largest region in the preclinical assets market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preclinical assets market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Scope and Reach of the Preclinical Assets Market Defined?

A preclinical asset refers to all clinical trial supplies or equipment for preclinical development that encompasses the activities that link drug discovery in the laboratory to the initiation of human clinical trials. This phase precedes human clinical trials and entails essential feasibility assessments, iterative evaluations, and safety data gathering, typically performed on laboratory animals.

Browse Through More Similar Reports By The Business Research Company:

Asset-Backed Securities Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/asset-backed-securities-global-market-report

Preclinical Imaging Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

Defense IT Spending Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/defense-it-spending-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: